Adagene vs Coya Therapeutics
Adagene and Coya Therapeutics are similar in size: $7.7m and $7.9m of revenue in their latest fiscal years. Adagene grew faster (7332.8% against 123.6%). Adagene kept more of each dollar of sales as profit: a net margin of -229.6% against -267.1%. Coya Therapeutics carries less debt relative to equity (0.0% against 17.3%).
| Latest fiscal year | AdageneADAG, 2025 | Coya TherapeuticsCOYA, 2025 |
|---|---|---|
| Revenue | $7.7m | $7.9m |
| Revenue growth | 7332.8% | 123.6% |
| Net income | −$17.6m | −$21.2m |
| Operating margin | -279.5% | -283.9% |
| Net margin | -229.6% | -267.1% |
| Return on equity | -41.0% | -51.4% |
| Free cash flow | −$15.7m | — |
| Cash | $74.5m | $46.8m |
| Total debt | $6.1m | $0 |
| Debt to equity | 17.3% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | — |
| Market value | $113m | $73.5m |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 5 buys, 0 sales | 0 buys, 0 sales |